GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.714
EU - Europa 17.973
AS - Asia 16.079
SA - Sud America 2.109
AF - Africa 391
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 20
Totale 69.331
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.006
IT - Italia 7.025
SG - Singapore 4.792
GB - Regno Unito 4.681
CN - Cina 4.212
HK - Hong Kong 1.814
BR - Brasile 1.612
VN - Vietnam 1.492
SE - Svezia 1.236
BD - Bangladesh 1.079
DE - Germania 977
FI - Finlandia 888
FR - Francia 773
UA - Ucraina 601
RU - Federazione Russa 579
KR - Corea 559
TR - Turchia 539
IN - India 409
CA - Canada 360
ID - Indonesia 295
NL - Olanda 247
BG - Bulgaria 233
MX - Messico 193
AR - Argentina 188
JP - Giappone 160
ZA - Sudafrica 133
IQ - Iraq 99
IE - Irlanda 96
ES - Italia 95
PL - Polonia 91
AE - Emirati Arabi Uniti 86
PK - Pakistan 82
AT - Austria 69
MY - Malesia 66
CO - Colombia 64
EC - Ecuador 63
BE - Belgio 56
EG - Egitto 51
LT - Lituania 51
CL - Cile 47
MA - Marocco 47
SA - Arabia Saudita 44
VE - Venezuela 43
TN - Tunisia 42
AU - Australia 40
RO - Romania 40
PH - Filippine 39
IR - Iran 38
CZ - Repubblica Ceca 33
PE - Perù 32
CH - Svizzera 31
NP - Nepal 30
PY - Paraguay 29
TH - Thailandia 28
UZ - Uzbekistan 28
BZ - Belize 27
KE - Kenya 26
JO - Giordania 24
CR - Costa Rica 23
TW - Taiwan 23
AZ - Azerbaigian 19
JM - Giamaica 19
AL - Albania 18
ET - Etiopia 17
PT - Portogallo 17
HU - Ungheria 16
OM - Oman 16
DZ - Algeria 15
GR - Grecia 15
BY - Bielorussia 14
IL - Israele 14
BO - Bolivia 13
EU - Europa 13
UY - Uruguay 13
DO - Repubblica Dominicana 12
LV - Lettonia 12
GT - Guatemala 11
HN - Honduras 11
SN - Senegal 11
BB - Barbados 10
DK - Danimarca 10
KZ - Kazakistan 10
PS - Palestinian Territory 10
KG - Kirghizistan 9
BH - Bahrain 8
GE - Georgia 8
NG - Nigeria 8
RS - Serbia 8
SY - Repubblica araba siriana 8
EE - Estonia 7
LU - Lussemburgo 7
MD - Moldavia 7
PR - Porto Rico 7
SI - Slovenia 7
SV - El Salvador 7
TT - Trinidad e Tobago 7
BA - Bosnia-Erzegovina 6
HR - Croazia 6
NI - Nicaragua 6
NO - Norvegia 6
Totale 69.204
Salva come PNG Salva come JPEG
Città #
Southend 3.361
Santa Clara 3.187
Singapore 3.054
Ashburn 2.877
Fairfield 2.600
Hong Kong 1.785
Woodbridge 1.481
San Jose 1.479
Hefei 1.420
Chandler 1.325
Houston 1.223
Jacksonville 952
Seattle 948
Chicago 928
Wilmington 918
Council Bluffs 867
Los Angeles 840
Cambridge 829
Ann Arbor 740
London 686
Nyköping 679
Helsinki 668
Beijing 643
Dearborn 622
Milan 567
New York 519
Seoul 507
Ho Chi Minh City 477
Rome 440
Salt Lake City 428
The Dalles 423
Modena 399
Hanoi 375
Izmir 298
San Diego 289
Lauterbourg 253
Bologna 238
Princeton 237
Buffalo 235
Sofia 224
Jakarta 219
Dallas 211
Tampa 199
Elk Grove Village 168
Moscow 162
Eugene 157
São Paulo 156
Naples 155
Frankfurt am Main 153
Shanghai 151
Florence 130
Atlanta 121
Bremen 120
Orem 112
Palermo 111
Redwood City 104
Des Moines 102
Tokyo 97
Columbus 95
Phoenix 94
Toronto 94
Munich 93
Mexico City 87
Boardman 86
Guangzhou 86
Dublin 80
Lancaster 80
Sterling 80
Turin 79
Bari 78
Catania 77
Parma 77
Montreal 72
Chennai 70
Da Nang 70
Denver 69
Miami 69
Warsaw 67
Detroit 66
Kent 65
Johannesburg 64
Genoa 60
Falls Church 59
Haiphong 59
Verona 58
Redondo Beach 54
Amsterdam 52
Reggio Emilia 51
Stockholm 51
Manchester 50
Norwalk 50
Dulles 49
Brooklyn 47
Padova 47
New Delhi 44
San Francisco 44
Mumbai 43
Ovada 43
Belo Horizonte 42
Lappeenranta 42
Totale 45.392
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.865
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 965
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 785
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 763
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 486
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 463
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 449
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 443
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 438
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 426
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 393
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 392
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 392
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 386
Thymus alterations and systemic sclerosis 385
Heart involvement and systemic sclerosis 381
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 376
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 374
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 374
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 373
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 369
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 369
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 359
Current treatment of hepatitis C-associated rheumatic diseases. 359
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 358
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 357
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 353
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 349
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 347
Scleroderma digital ulcers complicated by infection with fecal pathogens. 346
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 343
Elevated Troponin Serum Levels in Adult Onset Still's Disease 342
Aortic pulse wave velocity measurement in systemic sclerosis patients. 342
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 341
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 336
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 334
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 329
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 328
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 326
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 325
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 325
L-Arginine in pregnant scleroderma patients 325
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 324
Associations between Systemic Sclerosis and Thyroid Diseases 324
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 322
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 321
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 319
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 317
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 317
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 317
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 316
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 312
Platelet gel in the treatment of severe scleroderma skin ulcers. 312
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 309
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 308
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 308
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 307
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 302
HHV-6A infection and systemic sclerosis: Clues of a possible association 298
HCV and cryoglobulinemic vasculitis. 296
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 295
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis 293
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 291
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 289
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 289
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 287
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 287
Cardiovascular risk and prostanoids in systemic sclerosis 285
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 285
HCV associated cryoglobulinemic vasculitis 281
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 281
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 281
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 281
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 280
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 280
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 279
Amlodipine in the treatment of Raynaud's phenomenon 277
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 276
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 276
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 275
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 274
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 272
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 270
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 269
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 265
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 264
Renal Manifestations of Hepatitis C Virus 263
Systemic sclerosis following human cytomegalovirus infection 262
HCV-related rheumatic manifestations and therapeutic strategies 260
The safety of iloprost in systemic sclerosis in a real-life experience 260
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 259
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 259
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 259
Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome 258
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 257
Treatment of HCV-related mixed cryoglobulinemia 256
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 256
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 255
Novel Therapies for Thyroid Autoimmune Diseases 255
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 254
Totale 36.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 268.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 268.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.403 221 363 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/202512.041 472 216 243 827 2.233 1.779 830 635 1.329 769 1.254 1.454
2025/202626.057 1.487 901 1.908 3.429 4.661 1.679 2.907 1.147 2.189 2.092 2.084 1.573
2026/2027902 902 0 0 0 0 0 0 0 0 0 0 0
Totale 69.921